
differenti colgat time
emerg market exposur
except strong market share posit particularli latin america focus
portfolio high margin long runway categori develop oral
oversea market vi vi household penetr usag
backdrop continu improv develop market posit
us somewhat overshadow slow trend emerg market
sure colgat midst implement small strateg shift market-bi
market basi better align highest growth market segment channel
step advertis support innov pipelin build still found
commentari around latin america categori growth promot environ
worri
latin america comment friday call made us wonder colgat view
long-term increment consumption/usag opportun latin america may
chang sure price becom challeng simpli assum
price-l competit slower growth environ rather
dictat macroeconom inflat perhap black white
suggest long-term categori growth reli inflat jar volume-
base opportun histor healthi driver growth region
move busi tend receiv much less attent investor
oral said busi emerg notabl headwind
north america latin america top-lin growth recent quarter wonder
reason spend time analyz colgat portfolio outsid oral
market share solid domin equiti mainstream rather
profession support colgat work close dental profess global
thu benefit pharmaceut credenti stand reason
far disruptor local brand activ mani market around world
pt lower
cl quarterli annual ep usd
consensu number thomson reuter receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
lower usd
return equiti ttm
link barclay live interact chart
execut strategi remark market share
leav us construct compani potenti
reacceler growth bolster profit
also expect share continu
bake degre takeout premium near
assum cl share trade premium
large-cap stapl peer group trade
premium market ep estim
assum cl share trade premium
large-cap stapl peer group trade
discount market ep estim
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
develop market
posit us
somewhat overshadow
slow trend emerg
context colgat
histor perform latin
america suggest
reli inflat rather
volume-bas opportun
jar
cl valuat rel resili versu larg cap consum stapl market
heavili rotat sector share held price-to-earnings peer
averag sunk someth closer mid-teen level compani gener seen
uniqu best-in-class asset investor strateg acquir alik
differenti colgat time emerg market exposur except strong
market share posit particularli latin america focus portfolio high margin
peopl brush teeth less compani
geograph footprint assumpt still long runway
categori develop oral account roughli colgat revenu
context import cl organ revenu fall bp short
street estim albeit spot-in line composit come
pretti much opposit expect develop market continu
recoveri tick versu benefit easi comparison
normal promot environ us dish care e-commerc expans
hill premium channel product effort europ elmex pharmaci sanex
time emerg market slow compani specif cite step-up
promot environ intra-quart
though know colgat midst implement small strateg shift market-
by-market basi better align highest growth market segment channel
step advertis support innov pipelin build find two theme
quarter result confer call worri specif struck
commentari around latin america categori growth promot environ
comment friday call made us wonder colgat view long-term
increment consumption/usag opportun latin america may chang
specif call slower categori growth rate peg lower inflat
clear colgat result past two quarter price becom challeng
trend seen sinc simpli assum
price-l competit slower growth environ rather dictat
macroeconom inflat perhap black white suggest
long-term categori growth reli inflat rather volume-bas opportun
jar suddenli year prior financi crisi seem like ancient histori
year begin colgat volum latin america grew averag price
rang fair inflat weve seen year date
brazil point us volum perform dramat stronger market
share alreadi domin though perhap competit less signific qualiti
local competitor multi-n particip person care today
contribut volume/mix organ growth latin america histor much healthier manag
colgat right admir
unmatch capabl
domin posit oral
might
busi
put damper overal
oral tradit receiv bulk attent colgat portfolio
wonder shouldnt spend time analyz balanc portfolio
recal greatest persist drag colgat north america result
hand dish soap busi accord nielsen account roughli
region sale busi get much investor attent think
compani gener manag solid sourc cash flow quit shock
see sale trend double-digit rate follow brand re-stag
price came bp latin america busi
central america call one area weak local competit
perk cite busi colgat chose
follow un-econom promot sale growth suffer result chain
event gotten us wonder whether reason spend time
analyz person busi market share solid
domin equiti mainstream rather profession support colgat
work close dental profess global thu benefit pharmaceut
credenti stand reason far disruptor local brand
activ mani market around world colgat right admir
unmatch capabl domin posit oral might
busi put damper overal corpor perform
chang model take full-year estim organ sale growth
expect stronger perform north america off-set
weak market expect gross margin bp note
manag guidanc tailwind product save posit
price/mix larg off-set pressur rise commod bp
yoy ship bp advertis bp all-in expect oper
margin bp note calcul oper profit exclud
non-servic relat pension cost line new account rule adopt industri
quarter lower ep estim new pt
base pe use new ep estim assum premium large-
cap stapl peer group trade premium market previou
price target base ep estim
lauren lieberman herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli
relat specif recommend view express research report
